The CMS estimates that U.S. national healthcare expenditures exceeded $2.7 trillion in 2011, representing 17.9% of total GDP. Increasingly, experts are focusing on the impact of medical costs associated with chronic disorders, which the CDC estimate to be responsible for as much as 75% of U.S. national healthcare expenditures. The burden of chronic diseases, and their costs, will continue to rise as the U.S. population simultaneously grows in size, becomes heavier, and ages.
As a case study, we look in depth at the multi-morbid HONDA population in the United States. These patients concurrently have hypertension, obesity, diabetes, and asthma and are notoriously noncompliant—each of these diseases is a modifiable risk factor that both exacerbates and increases the risk for severe complications and acute medical events that contribute to the astronomical U.S. healthcare spend.
Markets covered: United States.
Epidemiology: U.S. county-specific prevalence of hypertension, obesity, type 2 diabetes, asthma, and the multi-morbid population.
Primary research: Six interviewed experts:
- Medical director, U.S. health plan, <50,000 lives
- Medical director, U.S. health plan, >7 million lives
- Medical director, U.S. health plan, >10 million lives
- Pharmacy director, U.S. health plan, >3 million lives
- Professor of Medicine, Section of Endocrinology, Diabetes, and Metabolism, University of Chicago Pritzker School of Medicine, Chicago, Illinois
- Quality director, U.S. health plan, >250,000 lives